Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Interval Exercise Training (IET) Is Feasible and May Improve Cardiorespiratory Performance Prior to Hematopoietic Cell Transplantation

Mathew Meeneghan, MD, Anna Snavely, PhD, Abbie Smith-Ryan, PhD, Claudio L Battaglini, PhD, Bryce B Reeve, PhD, Ethan Basch, MD MSc, Antonia Bennett, PhD, Charlotte Shatten, MA, Brett Phillips, BS, Jonathan Serody, MD, PhD, Don A. Gabriel, MD PhD, Katarzyna Joanna Jamieson, MD, James Coghill, MD, Paul M. Armistead, MD PhD, Thomas C. Shea, MD, William A. Wood, MD MPH

Blood (2014) 124 (21): 2611.

https://doi.org/10.1182/blood.V124.21.2611.2611

Published: 2014

Journal Articles

High-Throughput Immunoglobulin Heavy Chain Variable Region Repertoire Analysis Of CD27+ B Cell Subsets From Patients With Chronic Gvhd

Prasanthi V. Tata, MS, Benjamin G. Vincent, MD, Pei-Fen Kuan, PhD, Corbin Jones, PhD, Jonathan Serody, MD, Stefanie Sarantopoulos, MD, PhD

Blood (2013) 122 (21): 2055.

https://doi.org/10.1182/blood.V122.21.2055.2055

Published: 2013

Journal Articles

IL-22 Is Critical To The Pathogenesis Of Cutaneous Gvhd Mediated By Th17 Cells

Hemamalini Bommiasamy, Ph.D., Laura Ott, Ph.D., Shelly West, B.S., LeShara M Fulton, Ph.D., Angela Panoskaltsis-Mortari, Bruce R Blazar, MD, Lynette Fouser, PhD, Jonathan Serody, MD

Blood (2013) 122 (21): 4482.

https://doi.org/10.1182/blood.V122.21.4482.4482

Published: 2013

Journal Articles

Aryl Hydrocarbon Receptor Deficient Donor T Cells Display Decreased Migration and Cause Reduced Or Enhanced Graft-Versus-Host Diseases In Different Transplant Models

Kaifeng Lisa Lin, PhD, LeShara M Fulton, Ph.D., Jonathan Serody, MD

Blood (2013) 122 (21): 4477.

https://doi.org/10.1182/blood.V122.21.4477.4477

Published: 2013

Journal Articles

Germinal Center Generation and Maintenance By T Follicular Helper Cells Is Required For The Development Of Chronic Gvhd Associated Bronchiolitis Obliterans In a Preclinical Model

Blood (2013) 122 (21): 292.

https://doi.org/10.1182/blood.V122.21.292.292

Published: 2013

Journal Articles

BCR Hyper-Responsiveness In B Cells From Patients With Chronic Gvhd Is Blocked With The Syk Inhibitor R406

Blood (2013) 122 (21): 910.

https://doi.org/10.1182/blood.V122.21.910.910

Published: 2013

Journal Articles

Effectiveness and Potential Strategies to Improve Outcomes Following Chemomobilization with Etoposide + G-CSF in Patients Undergoing Autologous Stem Cell Transplantation for Lymphoma

William A Wood, MD, MPH, Julia Whitley, BS, Ravi K Goyal, Paul M Brown, PhD, Andrew Sharf, Robert N Irons, PA, Kamakshi Rao, PharmD, Amber N Essenmacher, PA, Jonathan Serody, MD, James Coghill, MD, Paul M. Armistead, MD, PhD, Stefanie Sarantopoulos, MD, PhD, Don A. Gabriel, MD, PhD, Thomas C. Shea, MD

Blood (2011) 118 (21): 2083.

https://doi.org/10.1182/blood.V118.21.2083.2083

Published: 2011

Journal Articles

Beneficial Effect of Escalated Doses of Busulfan (BU) Delivered by Targeted Pharmacokinetics and Prolonged Continuous Infusion on Relapse Free and Overall Survival in Matched Related and Unrelated Allogeneic Transplant Patients with Hematologic Malignancies

Thomas C. Shea, MD, Christine Walko, PharmD, Anastasia Ivanova, PhD, Julia Whitley, BS, Kamakshi Rao, PharmD, Don A. Gabriel, MD, PhD, Terrance Comeau, MD, FRCPC, James Coghill, MD, Paul M Armistead, MD, PhD, Stefanie Sarantopoulos, MD, PhD, William A. Wood, MD, MPH, Jonathan Serody, MD

Blood (2011) 118 (21): 1940.

https://doi.org/10.1182/blood.V118.21.1940.1940

Published: 2011

Journal Articles

Erythroid Differentiation Regulator 1 (ERDR1) From Nurse-Like Cells Promotes the Survival of Chronic Lymphocytic Leukemia Cells

Hendrik W. Van Deventer, MD, MS, Robert Mango, Jonathan Serody, MD

Blood (2010) 116 (21): 1372.

https://doi.org/10.1182/blood.V116.21.1372.1372

Published: 2010

Journal Articles

Attenuated Acute Graft-Versus-Host Disease Following Allogeneic Stem Cell Transplantation In the Absence of RORγt.

LeShara M Fulton, BA, Michael J Carlson, PhD, James Coghill, MD, Michelle L. West, BS, Angela Panoskaltisis-Mortari, PhD, Bruce R. Blazar, MD, Dan Littman, PhD, Jonathan Serody, MD

Blood (2010) 116 (21): 3742.

https://doi.org/10.1182/blood.V116.21.3742.3742

Published: 2010

Journal Articles

Effect of CMX001 on Levels of DNA Virus In Patients After Allogeneic Stem Cell Transplantation.

Don A. Gabriel, MD, PhD, Julia Whitley, BS, Kamakshi Rao, PharmD, Charles van der Horst, MD, Jonathan Serody, MD, James Coghill, MD, Stefanie Sarantopoulos, MD, PhD, Paul Armistead, MD, PhD, William Wood, MD, MPH, Thomas C. Shea, MD

Blood (2010) 116 (21): 4550.

https://doi.org/10.1182/blood.V116.21.4550.4550

Published: 2010

Journal Articles

B Cells Are Primed for Survival by BAFF-Driven Bim Degradation In Chronic Graft Versus Host Disease (cGVHD) Patients

Jenna Wooten, PhD, Bhuiya S. Nazmim, MPH, Kristy Richards, PhD, MD, Andrew Sharf, Joseph H. Antin, MD, Robert J. Soiffer, MD, Jerome Ritz, MD, Thomas C. Shea, MD, Jonathan Serody, MD, Albert S. Baldwin, Jr., Ph.D., Stefanie Sarantopoulos, MD, PhD

Blood (2010) 116 (21): 216.

https://doi.org/10.1182/blood.V116.21.216.216

Published: 2010

Journal Articles

Bone Marrow Myeloid-Derived Suppressor Cells (MDSC) Inhibit Graft Versus Host Disease (GVHD) Via An Arginase-1 Dependant Mechanism That Is Upregulated by IL-13

Steven L Highfill, PhD, Paulo Rodriguez, PhD, Qing Zhou, PhD, Christine A Goetz, PhD, Rachelle Veenstra, Patricia A Taylor, DVM, Angela Panoskaltsis-Mortari, PhD, Jonathan Serody, MD, David Munn, Jakub Tolar, MD, PhD, Augusto C Ochoa, MD, Bruce R. Blazar, MD

Blood (2010) 116 (21): 241.

https://doi.org/10.1182/blood.V116.21.241.241

Published: 2010

Journal Articles

Vorinostat in Combination with Pegylated Liposomal Doxorubicin and Bortezomib for Patients with Relapsed/Refractory Multiple Myeloma: Results of a Phase I Study.

Peter M. Voorhees, MD, Cristina Gasparetto, MD, Kristy L. Richards, PhD, MD, Reynaldo Garcia, RN, OCN, John S. Strader, Madlyn Ferraro, RN, OCN, CCRC, Jennifer MacLean, RN, Diane Winans, Dominic T. Moore, PhD, Andrew Dodd, Matthew C. Foster, MD, Don A. Gabriel, MD, PhD, Thomas C. Shea, Jonathan Serody, MD, Hendrik W. van Deventer, MD, Syed Rizvi, Robert Z. Orlowski, M.D., Ph.D., David D. Hurd, MD

Blood (2009) 114 (22): 306.

https://doi.org/10.1182/blood.V114.22.306.306

Published: 2009

Journal Articles

Recruitment of Donor T Cells to Secondary Lymphoid Tissue Is Enhanced by Conditioning Therapy and Donor T Cells/Marrow

Jonathan Serody, MD, Chris A Wysocki, Tim P Moran

Blood (2008) 112 (11): 3506.

https://doi.org/10.1182/blood.V112.11.3506.3506

Published: 2008

Journal Articles

Low Incidence of GVHD and Treatment-Related Morbidity (TRM) with Intermediate Doses of Continuous Infusion IV Busulfan and Daily Fludarabine with Individualized Doses of Alemtuzamab for Matched Related (MRD) and Unrelated (MUD) Transplant Pts with High-Risk Hematologic Malignancies.

Thomas Shea, MD, Jonathan Serody, MD, PhD, Don Gabriel, MD, PhD, Terrance Comeau, MD, Anastasia Ivanova, PhD, Dominic Moore, PhD, Robert Irons, PA, Whitley Julia, BS, Sharf Andrew, RN, Cherie Dunphy, MD, Brecher Mark, MD

Blood (2007) 110 (11): 4940.

https://doi.org/10.1182/blood.V110.11.4940.4940

Published: 2007

Journal Articles

Symptomatic Improvement Following Intravesicular Cidofovir for the Management of BK Virus Associated Cystitis.

Larry W. Buie, PharmD, Kamakshi V. Rao, PharmD, Stacy Epstein, PharmD, Thomas C. Shea, MD, Terrence Comeau, MD, Don A. Gabriel, MD PhD, Robert Irons, PA, Barbara Eron, RN, Jonathan Serody, MD PhD

Blood (2007) 110 (11): 3007.

https://doi.org/10.1182/blood.V110.11.3007.3007

Published: 2007

Journal Articles

Mitoxantrone and Melphalan as Conditioning Regimen for Autologous Stem Cell Transplant for Multiple Myeloma.

Anne W. Beaven, MD, Terrance Comeau, MD, Andrew Sharf, RN, Dominic T. Moore, MPH, Jonathan Serody, MD, PhD, Thomas C. Shea, MD, Don A. Gabriel, MD, PhD

Blood (2006) 108 (11): 2945.

https://doi.org/10.1182/blood.V108.11.2945.2945

Published: 2006

Journal Articles

Long Term Effects on GVHD and Survival Following the Use of G-CSF Stimulated Bone Marrow Versus G-CSF Mobilized Peripheral Blood Stem Cells in HLA Matched Sibling Transplant.

Anne W. Beaven, MD, Thomas C. Shea, MD, Don A. Gabriel, MD, PhD, Terrance Comeau, MD, Robert Irons, PA, Dominic T. Moore, MS, MPH, Li Lin, MS, Andrew Sharf, RN, Carol Krasnov, Mark E. Brecher, MD, Jonathan Serody, MD, PhD

Blood (2005) 106 (11): 5385.

https://doi.org/10.1182/blood.V106.11.5385.5385

Published: 2005

Journal Articles

High Relapse Rate Following Alemtuzamab Use in Allogeneic Transplants for Myeloid Hematologic Malignancies.

Thomas C. Shea, MD, Jonathan Serody, MD, PhD, Don Gabriel, MD, PhD, Terrance Comeau, MD, Donald Harvey, PharmD, Robert Irons, PA, David Morris, MD, Andrew Sharf, RN, Carol Krasnov, Cherie Dunphy, MD, Nicholas Banderenko, MD, Mark Brecher, MD

Blood (2004) 104 (11): 1826.

https://doi.org/10.1182/blood.V104.11.1826.1826

Published: 2004

NARROW

Interval Exercise Training (IET) Is Feasible and May Improve Cardiorespiratory Performance Prior to Hematopoietic Cell Transplantation

High-Throughput Immunoglobulin Heavy Chain Variable Region Repertoire Analysis Of CD27+ B Cell Subsets From Patients With Chronic Gvhd

IL-22 Is Critical To The Pathogenesis Of Cutaneous Gvhd Mediated By Th17 Cells

Aryl Hydrocarbon Receptor Deficient Donor T Cells Display Decreased Migration and Cause Reduced Or Enhanced Graft-Versus-Host Diseases In Different Transplant Models

Germinal Center Generation and Maintenance By T Follicular Helper Cells Is Required For The Development Of Chronic Gvhd Associated Bronchiolitis Obliterans In a Preclinical Model

BCR Hyper-Responsiveness In B Cells From Patients With Chronic Gvhd Is Blocked With The Syk Inhibitor R406

Effectiveness and Potential Strategies to Improve Outcomes Following Chemomobilization with Etoposide + G-CSF in Patients Undergoing Autologous Stem Cell Transplantation for Lymphoma

Beneficial Effect of Escalated Doses of Busulfan (BU) Delivered by Targeted Pharmacokinetics and Prolonged Continuous Infusion on Relapse Free and Overall Survival in Matched Related and Unrelated Allogeneic Transplant Patients with Hematologic Malignancies

Erythroid Differentiation Regulator 1 (ERDR1) From Nurse-Like Cells Promotes the Survival of Chronic Lymphocytic Leukemia Cells

Attenuated Acute Graft-Versus-Host Disease Following Allogeneic Stem Cell Transplantation In the Absence of RORγt.

Effect of CMX001 on Levels of DNA Virus In Patients After Allogeneic Stem Cell Transplantation.

B Cells Are Primed for Survival by BAFF-Driven Bim Degradation In Chronic Graft Versus Host Disease (cGVHD) Patients

Bone Marrow Myeloid-Derived Suppressor Cells (MDSC) Inhibit Graft Versus Host Disease (GVHD) Via An Arginase-1 Dependant Mechanism That Is Upregulated by IL-13

Vorinostat in Combination with Pegylated Liposomal Doxorubicin and Bortezomib for Patients with Relapsed/Refractory Multiple Myeloma: Results of a Phase I Study.

Recruitment of Donor T Cells to Secondary Lymphoid Tissue Is Enhanced by Conditioning Therapy and Donor T Cells/Marrow

Low Incidence of GVHD and Treatment-Related Morbidity (TRM) with Intermediate Doses of Continuous Infusion IV Busulfan and Daily Fludarabine with Individualized Doses of Alemtuzamab for Matched Related (MRD) and Unrelated (MUD) Transplant Pts with High-Risk Hematologic Malignancies.

Symptomatic Improvement Following Intravesicular Cidofovir for the Management of BK Virus Associated Cystitis.

Mitoxantrone and Melphalan as Conditioning Regimen for Autologous Stem Cell Transplant for Multiple Myeloma.

Long Term Effects on GVHD and Survival Following the Use of G-CSF Stimulated Bone Marrow Versus G-CSF Mobilized Peripheral Blood Stem Cells in HLA Matched Sibling Transplant.

High Relapse Rate Following Alemtuzamab Use in Allogeneic Transplants for Myeloid Hematologic Malignancies.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only